Antibody discovery puts universal flu vaccine on horizon; Sinovac Biotech gains GMP certification for mumps vaccine plant in China;

> Protein Potential and Aduro BioTech team up to develop two malaria vaccines that will be administered in a sequential regimen. Release

> Sinovac Biotech received a GMP certification from the China State Food and Drug Administration for the company's mumps vaccine production plant. Release

> Pregnant women struggle to find a flu vaccine because many obstetricians don't offer the shot. Story

> Immune Targeting Systems announced positive Phase I data for its pan-strain influenza A T-cell vaccine. News

> Nonmedical vaccination opt-outs are on the rise in the U.S. Article

And Finally... An antibody discovery could put a universal flu vaccine on the horizon. Item

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

THIS WEEK: Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today!

Suggested Articles

Find out how PDA can help you succeed with custom solutions and training for your employees – at your facility, our facility, or virtually.

Iowa State University is working on a room-temp-stable nasal spray vaccine for COVID-19, and it recently tapped device maker Zeteo for support.

Pfizer's shot will go before an FDA expert panel on Dec. 10, with Moderna's review pegged for the 17th, Warp Speed chief Moncef Slaoui, Ph.D., said.